Third-line pharmacotherapy for type 2 diabetes erratum
CADTH
Record ID 32014000774
English
Authors' objectives:
Correction to an error identified in the CADTH report "Third-line pharmacotherapy for type 2 diabetes —update" published in July 2013
Authors' recommendations:
Correction to an error identified in the CADTH report "Third-line pharmacotherapy for type 2 diabetes —update" published in July 2013. The correction of this error did not alter the overall conclusions
regarding the comparative efficacy of the third-line drugs studied with respect to A1C.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/Diabetes%20Update%20-%20Erratum%20-%20Third-line.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Diabetes Mellitus, Type 2
- Metformin
- Hypoglycemic Agents
- Published Erratum
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.